The robust glycolytic activity observed in tumor cells is closely associated with the dysregulation of signaling molecules, particularly the aberrantly activated hypoxia-inducible factor 1-alpha (HIF1α) and c-Myc. This evidence concerns the gene MYC and neoplasm.